Patents by Inventor Daniel Wreschner

Daniel Wreschner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230085269
    Abstract: The present invention provides isolated monoclonal antibodies which bind to the MUC1 SEA domain. The invention also concerns the use of these antibodies in therapeutic and diagnostic methods.
    Type: Application
    Filed: March 11, 2021
    Publication date: March 16, 2023
    Applicants: BIOMODIFYING, LLC, Ramot at Tel-Aviv University Ltd.
    Inventors: Daniel Rubinstein, Daniel Wreschner
  • Publication number: 20080014210
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death in cancer cells. This invention relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 17, 2008
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Daniel Wreschner, Nechaama Smorodinsky, Merav Yoeli-Lerner
  • Publication number: 20050019324
    Abstract: The invention relates to methods of inhibiting proliferation or growth of tumor cells and/or inducing cell death relates to the use of antibodies, hybridomas and pharmaceutical compositions containing same, for inhibiting growth or proliferation and inducing death in epithelial, colon, lung, breast and ovarian tumor cells or other cells which express MUC1 proteins.
    Type: Application
    Filed: March 26, 2002
    Publication date: January 27, 2005
    Inventors: Daniel Wreschner, Nechama Smorodinsky, Merav Yoeli-Lerner